AIM Myocardial infarction (MI) remains a major cause of death and disability worldwide, despite available reperfusion therapies. Inflammatory signaling is considered nodal in defining final infarct size. Activation of the innate immune receptor toll-like receptors (TLR) 9 prior to ischemia and reperfusion (I/R) reduces infarct size, but the consequence of TLR9 activation timed to the onset of i...

the important role of reperfusion therapies in the treatment of acute myocardial infarction is well documented. however, reperfusion therapies can initiate inflammatory response and may damage the myocardium. the purpose of current study was to compare the effects of percutaneous coronary intervention and thrombolytic therapy on inflammatory markers in the setting of st elevation myocardial inf...